Orgenesis Stock Buy Hold or Sell Recommendation

ORGS -  USA Stock  

USD 4.78  0.13  2.65%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Orgenesis is 'Strong Sell'. Macroaxis provides Orgenesis buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ORGS positions. The advice algorithm takes into account all of Orgenesis' available fundamental, technical, and predictive indicators you will find on this site.

Search Advice 

 
Refresh
The advice is provided from Orgenesis' buy-and-hold perspective. Please check Orgenesis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Orgenesis and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Orgenesis.

Execute Orgenesis Buy or Sell Advice

The Orgenesis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Orgenesis. Macroaxis does not own or have any residual interests in Orgenesis or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Orgenesis' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell OrgenesisBuy Orgenesis
Strong Sell

Volatility

Relatively riskyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Very HighDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Analyst Consensus

Strong BuyDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Orgenesis has a Mean Deviation of 3.42, Semi Deviation of 4.28, Standard Deviation of 5.09, Variance of 25.93, Downside Variance of 20.09 and Semi Variance of 18.33
We provide trade recommendations to complement the recent expert consensus on Orgenesis. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Orgenesis is not overpriced, please check all Orgenesis fundamentals, including its price to book, current ratio, working capital, as well as the relationship between the net income and number of employees . Given that Orgenesis has a price to earning of 16.56 X, we recommend you to check out Orgenesis market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Orgenesis Trading Alerts and Improvement Suggestions

Orgenesis has very high historical volatility over the last 90 days
Orgenesis has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 15.16 M. Net Loss for the year was (83.17 M) with profit before overhead, payroll, taxes, and interest of 7.65 M.
Orgenesis currently holds about 41.84 M in cash with (68.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Latest headline from finance.yahoo.com: Would Shareholders Who Purchased Orgenesis Stock Three Years Be Happy With The Share price Today - Yahoo Finance

Orgenesis current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Orgenesis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Orgenesis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price9.00
Target Median Price9.00
Target High Price9.00
Recommendation Mean2.00
Number Of Analyst Opinions1
Target Low Price9.00
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Orgenesis Returns Distribution Density

The distribution of Orgenesis' historical returns is an attempt to chart the future uncertainty of Orgenesis' future price movements. The chart of the probability distribution of Orgenesis stock daily returns describes the distribution of returns around its average expected value. We use Orgenesis price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Orgenesis returns is essential to provide solid investment advice for Orgenesis stock.
Mean Return0.15Value At Risk-6.78
Potential Upside7.61Standard Deviation5.09
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Orgenesis historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Orgenesis Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Orgenesis or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Orgenesis stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Orgenesis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.13
β
Beta against DOW0.24
σ
Overall volatility
5.17
Ir
Information ratio 0.0164

Orgenesis Volatility Alert

Orgenesis exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Orgenesis individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Orgenesis future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Orgenesis' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Orgenesis' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Orgenesis Fundamentals Vs Peers

Comparing Orgenesis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Orgenesis' direct or indirect competition across all of the common fundamentals between Orgenesis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Orgenesis or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Orgenesis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Orgenesis to competition
FundamentalsOrgenesisPeer Average
Return On Equity(122.25) %(0.31) %
Return On Asset(52.72) %(0.14) %
Operating Margin(582.24) %(5.51) %
Current Valuation102.92 M16.62 B
Shares Outstanding24.48 M571.82 M
Shares Owned by Insiders5.47 %10.09 %
Shares Owned by Institutions27.07 %39.21 %
Number of Shares Shorted1.83 M4.71 M
Price to Earning16.56 X28.72 X
Price to Book2.14 X9.51 X
Price to Sales7.72 X11.42 X
Revenue15.16 M9.43 B
Gross Profit7.65 M27.38 B
EBITDA(87.78 M)3.9 B
Net Income(83.17 M)570.98 M
Cash and Equivalents41.84 M2.7 B
Cash per Share1.71 X5.01 X
Total Debt12.85 M5.32 B
Debt to Equity0.23 %48.70 %
Current Ratio2.89 X2.16 X
Book Value Per Share2.23 X1.93 K
Cash Flow from Operations(68.9 M)971.22 M
Short Ratio11.10 X4.00 X
Earnings Per Share(2.79) X3.12 X
Number of Employees11118.84 K
Beta1.16-0.15
Market Capitalization117.01 M19.03 B
Total Asset36.55 M29.47 B
Retained Earnings(82.6 M)9.33 B
Working Capital(9.63 M)1.48 B
Current Asset5.29 M9.34 B
Current Liabilities14.92 M7.9 B
Z Score-4.08.72
   Purchase by David Sidransky of tradable shares of Orgenesis [view details]

Orgenesis Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Orgenesis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution573.4
Daily Balance Of Power(1.44)
Rate Of Daily Change0.97
Day Median Price4.81
Day Typical Price4.8
Market Facilitation Index0.0
Price Action Indicator(0.09)

About Orgenesis Buy or Sell Advice

When is the right time to buy or sell Orgenesis? Buying financial instruments such as Orgenesis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Orgenesis investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Orgenesis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cancer Fighters Thematic Idea Now

Cancer Fighters
Cancer Fighters Theme
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. Cancer Fighters theme has 60 constituents.
View All  Next Launch Cancer Fighters
Please check Orgenesis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Orgenesis Stock analysis

When running Orgenesis price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine Orgenesis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.